(Source = Newsis/NEWSIS)
[서울=뉴시스] Reporter Kim Gyeong-taek = Green Cross MS It was an item that received attention as a stock related to monkeypox in May and June of last year. At the time, while the stock price of Green Cross MS was on a downward trend starting from the 2020 Corona 19 pandemic, the outbreak of monkeypox showed a sparkling rise, with the stock price doubling in a month.
According to the financial investment industry on the 6th, the stock price of Green Cross MS, a KOSDAQ-listed company, went from 6,960 won on May 20, last year, when concerns over the spread of monkeypox began to be known in earnest in Korea, to 12,500 won on June 3, the same year. % soared.
At that time, besides Green Cross MS, related stocks such as Myco Biomed, Pharmicell, and HK Innoen all rose sharply.
It is evaluated that the news that a confirmed case of monkeypox has occurred abroad while the Corona 19 pandemic has calmed down worked as a new material for stock prices. Green Cross MS has conducted research to develop a smallpox vaccine in the past, so it was classified as a monkeypox-related stock.
Green Cross MS was also tied to stocks related to COVID-19 diagnostic kits before jumping on the monkeypox theme. In September 2020, when Corona 19 was prevalent, stock prices soared significantly after receiving permission to export Corona 19 antigen diagnostic kits from the Ministry of Food and Drug Safety. On August 28 of the same year, the stock price stayed at 10,350 won, but the stock price rose to 19,950 won as the upward trend continued until September 8, starting with two upper limits.
However, as new confirmed cases and demand for diagnostic kits decreased, the stock price also rapidly declined, and the stock price fell to around 7,000 won before the outbreak of monkeypox.
Since then, on June 21 of last year, the Korea Centers for Disease Control and Prevention announced that the first monkeypox patient had occurred in Korea, and related issues continued, but the stock price of Green Cross MS continued to rise. An analysis showed that the contagiousness of monkeypox was quite low, and unlike Corona 19, vaccines and treatments were already available, so it is interpreted that expectations quickly cooled.
The stock price of Green Cross MS has gone downhill this year as well, dropping from 5,780 won at the end of last year to 3,875 won on the 26th of last month, breaking a new 52-week low. Compared to the time when the stock price soared due to monkeypox, it is a one-third cut. However, as the rebound continued from this point, the previous day’s closing price rose to 4,530 won.
☞ Sympathy Media Newsis mrkt@newsis.com <저작권자ⓒ 공감언론 뉴시스통신사. 무단전재-재배포 금지.>
Copyright © Sympathetic Media Newsis News Agency. Unauthorized reproduction – redistribution prohibited
2023-08-06 05:00:00
#Green #Cross #drew #attention #monkeypox #급등주 #지금은
